SHR1258

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR1258, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR1258 in Patients With Biliary Tract Cancer [Phase 2]